ImportRefusal LogoImportRefusal

Biotech Industry

⚠️ Moderate Risk

FEI: 3003165206 • Luxemburg • LUXEMBOURG

FEI

FEI Number

3003165206

📍

Location

Luxemburg

🇱🇺

Country

LUXEMBOURG
🏢

Address

212 Rue Bernard Haal, , Luxemburg, , Luxembourg

Moderate Risk

FDA Import Risk Assessment

49.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
3
Unique Violations
6/13/2002
Latest Refusal
10/16/2001
Earliest Refusal

Score Breakdown

Violation Severity
80.0×40%
Refusal Volume
33.5×30%
Recency
0.0×20%
Frequency
70.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

2375×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

711×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

Refusal History

DateProductViolationsDivision
6/13/2002
80LDQDEVICE, GENERAL MEDICAL
237NO PMA
New Orleans District Office (NOL-DO)
6/13/2002
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
71NO LICENSE
New Orleans District Office (NOL-DO)
5/9/2002
80LDQDEVICE, GENERAL MEDICAL
508NO 510(K)
New Orleans District Office (NOL-DO)
3/25/2002
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
237NO PMA
New York District Office (NYK-DO)
3/20/2002
79MDMINSTRUMENT, MANUAL, GENERAL SURGICAL
237NO PMA
New Orleans District Office (NOL-DO)
3/20/2002
79MDMINSTRUMENT, MANUAL, GENERAL SURGICAL
237NO PMA
New Orleans District Office (NOL-DO)
10/16/2001
80LDQDEVICE, GENERAL MEDICAL
237NO PMA
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Biotech Industry's FDA import refusal history?

Biotech Industry (FEI: 3003165206) has 7 FDA import refusal record(s) in our database, spanning from 10/16/2001 to 6/13/2002.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Biotech Industry's FEI number is 3003165206.

What types of violations has Biotech Industry received?

Biotech Industry has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Biotech Industry come from?

All FDA import refusal data for Biotech Industry is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.